The FDA has approved Medicis’ hyaluronic acid with lidocaine dermal fillers, Restylane-L and Perlane-L. This approval was based on clinical data that demonstrated Restylane-L and Perlane-L to ...

SCOTTSDALE, Ariz., April 27, 2011 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the U.S. Food and Drug Administration's (FDA) General and Plastic Surgery Devices Advisory Panel (the ...

"The first thing we look for is the ability to personalize treatment plans, because every face is different and has different needs," says Dr. Henry. One filler brand she says offers her "the tool kit ...

- Galderma reinforces long-term commitment to meet physician and patient needs in aesthetic and corrective dermatology worldwide Restylane, Perlane and Emervel are manufactured by Galderma and sold by ...

(MENAFN- PR Newswire) FORT WORTH, Texas, Sept. 30, 2021 /PRNewswire/ -- Galderma, the world's largest independent dermatology company, today marks the 25th anniversary of RESTYLANE®. Since launching ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted market approval to Restylane Lyft with lidocaine for cheek augmentation and correction of ...

The FDA has approved Restylane® Kysse (Galderma) for lip augmentation and the correction of upper perioral rhytids in adults aged >21 years. The Food and Drug Administration (FDA) has approved ...

(MENAFN- PR Newswire) FORT WORTH, Texas, Feb. 2, 2021 /PRNewswire/ -- Galderma announces that the U.S. Food and Drug Administration (FDA) has approved Restylane® Defyne for the augmentation and ...

Regulatory authorities in the European Union (EU), the United States (U.S.), and Canada have approved a new state-of-the-art Restylane syringe for use with a range of Restylane NASHA lidocaine ...

Evolus dermal filler, Evolysse™ Lift, met primary endpoint of non-inferiority and demonstrated superiority to Restylane-L at 6 months; Secondary endpoints for improvement in nasolabial fold severity ...

Men and nonsurgical facial procedures (i.e., in-office injectables, such as fillers like Restylane) are having a moment together—the numbers simply don't lie. Cosmetic surgery, as well as nonsurgical ...